Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • T199Y
    Junior Member
    • Mar 2011
    • 2

    Calculating capture efficiency

    Hi all,

    I want to calculate what percentage of my sequenced custom capture is actually off-target and I can't get my head around how to do this - does anyone have any tips?

    Many thanks.
  • Heisman
    Senior Member
    • Dec 2010
    • 534

    #2
    A couple of ways you can do this.

    1. The easiest would be to create a reference sequence for your custom capture, and then align your data to the whole genome and your custom reference sequence (give your custom reference sequence 500 bp flanking region). Then see how many reads align to the whole genome but don't align to your custom capture. There may be a bit of ambiguity due to some reads aligning to the custom capture that don't align to the whole genome if they have high homology to multiple portions of the human genome, but this won't be a big issue from my experience.

    2. If you have aligned to the whole genome and don't want to go through the trouble aligning to the custom reference sequence, you can run GATK depth of coverage for the whole genome and also for the specific targeted intervals (again, + and - 500bp flanking regions). Then compare the total amount of coverage.

    Comment

    • Jon_Keats
      Senior Member
      • Mar 2010
      • 279

      #3
      Try Picard (http://picard.sourceforge.net/comman...ulateHsMetrics)

      Comment

      • swbarnes2
        Senior Member
        • May 2008
        • 910

        #4
        I use BEDTools. Get a .bed file of your capture regions. Align to the whole genome (which is in general a better idea than just aligning to target region), then intersect your whole genome .bam with the .bed file. You might pad the bed file first, though if you use the exact coordiantes, you will not lose reads that hang off your target region.

        Then count (with samtools flagstat, or something like that) how many lines are in your bam before and after filtering.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Today, 11:41 AM
        0 responses
        9 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        34 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        44 views
        0 reactions
        Last Post SEQadmin2  
        Working...